DUSP18 and neoplasm: In contrast tumor samples with low DUSP18 expression showed higher enrichment scores of T cell inflammatory gene expression profile, innate anti-PD-1 resistance, immuno-predictive score signatures and PD-1 response signatures (Supplementary Fig. 9f).